Impact of Antibiotic Therapy on Ventilator-Associated Pneumonia Outcomes
Author Information
Author(s): Goncalves-Pereira J, Sequeira T, Moya B, Cardoso T, Catorze N
Primary Institution: Hospital Sao Francisco Xavier, Lisboa, Portugal
Hypothesis
The study aims to assess the impact of empiric antibiotic adequacy on ICU outcomes for patients with ventilator-associated pneumonia.
Conclusion
Adequate empiric antibiotic therapy is linked to lower mortality rates in patients with ventilator-associated pneumonia.
Supporting Evidence
- Empiric antibiotic therapy was adequate in 65.9% of patients.
- ICU mortality was significantly lower for patients with adequate therapy (28.4%) compared to those with inadequate therapy (45.2%).
- Patients infected with multidrug-resistant organisms were more likely to receive inadequate antibiotic therapy (80.1%).
- Patients with inadequate therapy had a longer previous ICU stay (11.5 days) compared to those with adequate therapy (7.2 days).
Takeaway
If patients with pneumonia get the right antibiotics, they are less likely to die from it.
Methodology
A multiple-centre observational study was conducted over 24 months, analyzing adult patients with documented VAP and classifying their antibiotic therapy as adequate or inadequate.
Participant Demographics
Patients had an average age of 62.7 years, with 65.9% being men.
Statistical Information
P-Value
0.049
Statistical Significance
p = 0.049
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website